BC cells with CD44+CD24low/–, carrying the capacity of self-renewal, proliferative potential, and ability to produce differentiated progeny, are regarded as CSCs of BC (Wright et al., 2008; Ma et al., 2014; Chang et al., 2016). Here, CD44 is linked to breast cancer.